1 insider bought €91k of shares over the last 90 days, the latest filed 07 Aug 2026.
Photocure ASA is a Health Care company. Its directors and officers file their transactions with Oslo Børs. Between 18 October 2025 and 18 October 2026, 3 insiders published 4 filings.
Only purchases show up on the open market, 2 purchases in all worth €155k, filed by 2 insiders. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. At €91k, the purchase published on 7 August 2026 by Priyam Shah Vice is the largest of the period (0.071% of market cap).
Across the 257 companies tracked on its exchange, the median is 4 filings; at 4 filings, this issuer sits right on that mark. Since 2021, the database holds 10 purchases and 11 sales by insiders of the company.
The last purchase on record was published on 7 August 2026, which is 71 days ago.
In the same sector, recent insider purchases at Cooper Companies, Inc. and Cytosorbents Corp also feature in our signals. These figures are compiled from regulatory filings published by Oslo Børs. They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 38 declarations
Photocure ASA is a Norwegian company focused on developing photodynamic treatments for cancer. It is listed on the Oslo Stock Exchange.
Purchases our model currently ranks for the recommendations list.
All recommendations